Expiratory Flow Limitation Assessment
FLAIR
Expiratory Fow Assessment in ARDS Patients
2 other identifiers
interventional
25
1 country
2
Brief Summary
This study intended to assess the expiratory flow limitation (EFL) during tidal breath in patients intubated in intensive care unit (ICU) for moderate or severe acute respiratory distress syndrome (ARDS). EFL is defined as the lack of increase in expiratory flow in response to an increase in alveolar-to-atmospheric pressure gradient. It reflects airway closure. Early studies have been done using the Negative expiratory pressure (NEP) technique, which is no longer available. We proposed in present study a new method, which consists of diverting manually the expiratory flow to the atmosphere by-passing the expiratory valve. We aimed at assessing EFL at positive expiratory pressure (PEP) 5 cmH2O in semi-recumbent then in supine position together with measurement of trans-pulmonary pressure and regional lung ventilation. Higher PEP levels will be tested, namely 10, 15 and a trans-pulmonary PEP of 3 cmH2O, in semi-recumbent position.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2018
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2018
CompletedFirst Submitted
Initial submission to the registry
March 6, 2018
CompletedFirst Posted
Study publicly available on registry
March 13, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 2, 2019
CompletedDecember 5, 2025
November 1, 2025
1.2 years
March 6, 2018
November 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
EFL at PEP 5 cmH2O
A Fleish 2 pneumotachograph and a port to measure airway pressure are attached at the Y piece of the ventilator circuit and connected to a Biopac 150. At the end of inspiration the air is expelled to the atmosphere upstream the expiratory valve. The flow volume loop at baseline and that during the manoeuver are plotted and patients classified as EFL or not EFL (NFL). Measurements are taken in semi-recumbent then after 5 minutes in supine position.
at inclusion
Secondary Outcomes (16)
Trans-pulmonary pressure at end expiratory at PEP 5
at inclusion
Trans-pulmonary pressure at end expiratory at PEP 10 in EFL and NFL patients
15 minutes after PEP set to 10 cm H2O
Lung compliance at PEP 10 in EFL and NFL patients
15 minutes after PEP set to 10 cm H2O
lung ventilation distribution at PEP 10 in EFL and NFL patients
15 minutes after PEP set to 10 cm H2O
Transcutaneous oxygen saturation (SpO2) at PEP 10 in EFL and NFL patients
15 minutes after PEP set to 10 cm H2O
- +11 more secondary outcomes
Study Arms (2)
Patients with EFL at PEP 5
OTHERPatients with EFL at PEP 5 at the time of inclusion either in supine or semi-recumbent position
Patients with no EFL at PEP 5
OTHERPatients with no EFL at PEP 5 at the time of inclusion in both supine and semi-recumbent positions
Interventions
increase in positive end expiratory pressure from 5 to 10 then 15 cmH2O then at the value for trans pulmonary end expiratory pressure amounting to 3 cmH2O
Eligibility Criteria
You may qualify if:
- years or more in age
- moderate to severe ARDS according to the Berlin definition : Intubated (or tracheotomized) and mechanically ventilated in the ICU
- no pregnancy
- informed consent from the next of kin
You may not qualify if:
- Contra-indication to PEP \> 5 cmH2O
- extracorporeal membrane oxygenation (ECMO)
- chest tube
- mean arterial pressure \< 65 mmHg
- Contra-indication to oesophageal device
- underlying disease fatal in less than one year
- active therapy limitation
- under guardian
- refusal to participate
- not affiliated to insurance regimen
- speaking barrier of the next of kin
- investigator not available
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CHU Grenoble Alpes
Grenoble, France
Hôpital de la Croix Rousse
Lyon, 69004, France
Related Publications (1)
Guerin C, Terzi N, Galerneau LM, Mezidi M, Yonis H, Baboi L, Kreitmann L, Turbil E, Cour M, Argaud L, Louis B. Lung and chest wall mechanics in patients with acute respiratory distress syndrome, expiratory flow limitation, and airway closure. J Appl Physiol (1985). 2020 Jun 1;128(6):1594-1603. doi: 10.1152/japplphysiol.00059.2020. Epub 2020 Apr 30.
PMID: 32352339RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claude Guerin, Pr
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2018
First Posted
March 13, 2018
Study Start
February 5, 2018
Primary Completion
May 2, 2019
Study Completion
May 2, 2019
Last Updated
December 5, 2025
Record last verified: 2025-11